Gonadorelin

What is gonadorelin?

Gonadorelin is synthetic GnRH — identical in structure to the gonadotropin-releasing hormone your hypothalamus naturally produces in pulses to drive LH, FSH, and testosterone production. It's one of the most widely prescribed peptides in the men's health space, used almost universally alongside testosterone replacement therapy (TRT) to prevent the testicular atrophy and spermatogenesis suppression that TRT causes on its own.

The problem with TRT without gonadorelin is straightforward: exogenous testosterone suppresses the HPG axis via negative feedback. LH and FSH drop to near zero. The testes — deprived of LH stimulation — stop producing testosterone and begin to shrink. Sperm production ceases. For men who want to maintain testicular size, function, and fertility on TRT, something needs to maintain LH stimulation to the testes. That's gonadorelin's job: administered subcutaneously 2–3 times per week, it provides pulsatile GnRH stimulation to the pituitary, maintaining LH release, which in turn maintains testicular function.

The pulsatile/continuous distinction is the most important practical fact about gonadorelin: pulsatile = stimulating; continuous = suppressive. This is not a side effect — it's fundamental physiology established by Belchetz et al. (Science, 1978). Category 1 status under the 2026 reclassification has significantly expanded access through compounding pharmacies, making gonadorelin one of the most commonly prescribed peptides in men's health practices.

How it works

GnRH Receptor Activation — Pulsatile vs. Continuous

Gonadorelin binds GnRH receptors on anterior pituitary gonadotroph cells. In pulsatile administration: each pulse stimulates LH and FSH secretion, maintaining downstream testosterone production. In continuous administration: GnRH receptors desensitize and downregulate — LH and FSH fall, producing profound hypogonadism. This is why GnRH agonists like leuprolide are used in prostate cancer medical castration. Gonadorelin's practical use requires maintaining the pulsatile pattern (2–3x per week, not daily).

LH Maintenance During TRT and Spermatogenesis

When exogenous testosterone suppresses LH to near zero, Leydig cells lose stimulation and intratesticular testosterone falls dramatically — even though circulating testosterone is elevated. This drives testicular atrophy and impairs spermatogenesis. Pulsatile gonadorelin maintains LH pulses → Leydig cell stimulation → intratesticular testosterone → testicular volume. Gonadorelin also maintains FSH, which acts on Sertoli cells to support spermatogenesis — critical for men who want to preserve fertility potential on TRT.

HPG Axis Restoration Post-TRT

After stopping TRT, the HPG axis needs time to recover. Gonadorelin can be used during this transition to stimulate pituitary GnRH receptors and accelerate return of endogenous LH and FSH production — working at the GnRH receptor level rather than through estrogen blockade like SERMs (clomid, nolvadex). Some practitioners combine both approaches for faster HPG axis restoration.

What the research shows

What the community reports

Gonadorelin has moved from a niche TRT adjunct to one of the most discussed peptides in men's health communities — driven partly by the Category 1 reclassification making it compounding-accessible and partly by physicians specializing in men's health who now prescribe it as standard practice alongside TRT.

Common misconceptions